Defibrillators Market

Industry Overview

The global defibrillators market is expected to grow from USD 7.32 billion in 2023 to USD 12.57 billion by 2030 at a compound annual growth rate (CAGR) of 8.1% during the forecast period ranging from 2025 to 2030.

Defibrillator is a device used to deliver therapeutic high energy electric shock to the heart which causes depolarization of the heart muscles. It is used to treat various conditions such as cardiac arrhythmia, pulseless ventricular tachycardia and ventricular fibrillation. Defibrillators play a pivotal role in treating and managing a wide range of cardiovascular conditions, thereby contributing to market expansion.

The global defibrillators market is growing at a notable rate due to the rapid technological improvements and the rising incidents of target diseases. The market has witnessed high demand for implantable cardioverter defibrillators over the last few years due to technologically innovative devices, growing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and significant rise in the number of cardiovascular diseases. Increasing product development and research activities, growing incidence of sudden cardiac arrest, and rising awareness among the general public, along with the supportive initiatives by governments and healthcare organizations are some of the key factors that promotes the growth of the global defibrillators market.

The major challenges for the growth of defibrillators market include frequent product recall and lack of awareness about sudden cardiac arrest and problems related to the usage of implantable and mechanical external defibrillators. The major opportunities to the growth of the global defibrillators market are however presented by the strategies of the market players to introduce novel products and approvals to meet the unmet requirements and upsurge their market.

Market Segmentation

Insight by Product

The global defibrillators market is divided on the basis of product into implantable cardioverter defibrillators (ICDs) and external defibrillators segments. Out of these two segments, the implantable cardioverter defibrillators will account for the larger share in the market during the forecast period due to the higher growth in the number of implant procedures, technologically advanced devices with extended longevity, integration of other technologies such as pacemaker with defibrillator, and growing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and subcutaneous implantable cardioverter defibrillator (S-ICD) systems across the globe. Moreover, the external defibrillator is mainly used for recovery in case of sudden cardiac attack and alleviates the patient until medical help arrives or patient reach the hospital.

Insight by End-User

The global defibrillators market is divided on the basis of end users into hospitals, cardiac centers, and clinics, pre-hospital care settings, public access markets, home care settings and alternate care facilities. Out of all these segments, the public access markets segment will grow significantly during the forecast period due to growing occurrences of sudden cardiac arrest, adjustments in guidelines by governments of emerging economies to make it mandatory for specific conditions and the rise in the number of public access defibrillation programs.

Global Defibrillators Market Report Coverage

Report Metric	Details
Historical Period	2018 - 2023
Base Year Considered	2024
Forecast Period	2025 - 2030
Market Size in 2023	U.S.D.  7.32 Billion
Revenue Forecast in 2030	U.S.D.  12.57 Billion
Growth Rate	8.1%
Segments Covered in the Report	By Product and By End-User
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World

Industry Dynamics

Industry Trends

There is a notable growth in the demand for automated external defibrillators in prehospital setting. In addition, the rising pricing pressure on market players are resulting in the rise in the number of strategic mergers and acquisitions among them. Another major trend observed in the defibrillators market in that the manufacturers are now developing more effective and innovative devices that can minimize the risk of infection, allergies, and vein damage.

Growth Drivers

The mounting training and insomnia programs on defibrillator, and mounting focus on providing public-access defibrillators are the primary growth drivers for defibrillators market. Mounting occurrence of lifestyle associated diseases is fueling the growth of the market. Moreover, development of S-ICD and MRI-Compatible ICD & CRT-Ds, developing healthcare infrastructure in developing countries, helpful legislation guidelines and technological improvements are also fueling the demand or growth of the defibrillators market. The growing geriatric population globally, particularly those aged between 65 years and above, is more vulnerable to chronic diseases, which often require the placement of defibrillators to restore a normal heart rhythm by delivering an electric shock to the heart. With such increasing prevalence of CVDs and significant contribution of sudden cardiac arrest to cardiovascular-related deaths, the defibrillators market is propelling forward significantly.

Challenges

Across the world, a major hindrance to the entry of new players into the defibrillators market is the major hindrance to the growth and expansion. This is mainly attributed to the stringent regulatory standards as well as the high capital requirement.

Opportunities

The market growth opportunities are however offered by the initiatives of the market players to beat the fierce competition and increase their market share by regional expansion, partnerships and collaborations.

Geographic Overview

North America will contribute the larger share to the market during the forecast period due to the higher prevalence of cardiovascular disease and rise in the number of death cases due to heart disease. In addition, the growing geriatric population, increasing training and awareness programs, supportive government guidelines, growing healthcare expenditure, developed beneficial reimbursement policies, and technological improvement and product launches are some other significant factors propelling the growth of the defibrillators market in this region.

The Asia-Pacific market will also grow at a significant rate during the same projected period due to the large population base and the growing geriatric population who are prone to cardiovascular and other chronic diseases. The market growth in this region is also attributed to the rise in the number of lifestyle-related disease and CVDs, rising healthcare expenditure, growing disposable income, developing healthcare infrastructure, and significant growth in medical tourism.

Industry Ecosystem

Novel product introductions and approvals were major stratagems implemented by key industry players to upsurge their market share and provide unmet requirements. In addition, globally, the manufacturing companies trying to enter the cardiac monitoring and cardiac rhythm management market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players.

Geographic Overview

Geographically, North America is the largest defibrillators market as in the region the prevalence of cardiovascular disease is escalating. For instance, according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Moreover, according to CDC, approximately 370,000 people die annually due to coronary heart disease in the U.S. It is the most common type of heart disease in the U.S.

Expanding geriatric population, mounting training and wakefulness programs, reassuring government guidelines, mounting healthcare expenditure, developed beneficial reimbursement schemes, and technological improvement and product launches are also up surging growth of the North American defibrillators market.

Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base and mounting geriatric population. In addition, escalating occurrence of cardiovascular diseases, mounting healthcare expenditure, refining healthcare infrastructure and upsurge in medical tourism are also creating a positive impact on the defibrillators industry growth in the region.

Competitive Insight

Key players in the defibrillators market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. Medtronic Plc., Cardiac Science, St. Jude Medical, Nihon Kohden, Boston Scientific, Philips, Biotronik, Zoll Medical, Physio-Control, Livanova, and Schiller are the key players offering defibrillators.

Biotronik is a limited partnership multi-national cardiovascular biomedical research and technology company, headquartered in Berlin, Germany. The company offers equipment for diagnosis, treatment, and therapy support in the areas of cardiac rhythm management, electrophysiology, and vascular intervention.

Medtronic plc is an American-Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota. 

Recent Developments by Key Players

Medtronic plc (a global leader in healthcare technology), announced that its investigational OmniaSecure defibrillation lead met its primary safety and effectiveness endpoints, exceeding prespecified performance goals, in the global Lead Evaluation for Defibrillation and Reliability Pivotal Trial. 

Biotronik shall solely supply the proprietary DX models for new single-chamber implantable cardioverter-defibrillators (ICDs) implants.

The Defibrillators Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Product
  • External Defibrillators
  • Implantable Cardioverter Defibrillators
• By End-User
  • Home Care Settings
  • Hospitals
  • Clinics
  • Cardiac Centers
  • Public Access
  • Pre-Hospital Care Settings
  • Alternate Care Facilities

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research